The COVID-19 pandemic has significantly affected healthcare markets globally. To assess this impact in the APAC region, DRG conducted interviews with stakeholders from prominent APAC facilities to investigate how inventory management strategies, communication with suppliers, and future purchasing processes have changed in response to COVID-19.
The webinar included a 30 minute presentation of the methodology and results of DRG’s medtech market forecasts, highlighting COVID-19’s impact on APAC markets along with an overview of results from interviews with stakeholders from prominent APAC facilities, providing insights into the impact of COVID-19 on inventory management strategies, communication with suppliers, and possible changes to future purchasing decisions.
This was followed by a session with Art Butcher, the Executive Vice President and President at Boston Scientific, Probir Das, the Chairman and Managing Director at Terumo Holdings, and Effie Wu, Asia Pacific Supply Chain Lead at Ethicon, Johnson & Johnson in a Fireside Chat, moderated by Andrew Lee, Vice President at MedTech at Decision Resources Group.
